Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Email: |
3003867561@qq.com |
Products Intro: |
Product Name:DYRKs-IN-1 CAS:1387090-01-8 Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg
|
Company Name: |
Beijing Jin Ming Biotechnology Co., Ltd.
|
Tel: |
010-60605840 15801484223; |
Email: |
psaitong@jm-bio.com |
Products Intro: |
Product Name:DYRKs-IN-1 CAS:1387090-01-8 Package:100mg;250mg;1g Remarks: 试剂级
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:DYRKs-IN-1 CAS:1387090-01-8 Package:25mg/RMB 20500;50mg/RMB 27300;100mg/RMB 35500
|
|
| DYRKs-IN-1 Basic information |
Product Name: | DYRKs-IN-1 | Synonyms: | DYRKs-IN-1;DYRKsIN1,DYRKs IN 1;Pyrido[2,3-d]pyrimidine-6-carboxamide, N-[5-[[(3-amino-1-phenylpropyl)amino]carbonyl]-2-chlorophenyl]-7,8-dihydro-2-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-7-oxo- | CAS: | 1387090-01-8 | MF: | C30H30ClN7O4 | MW: | 588.06 | EINECS: | | Product Categories: | | Mol File: | 1387090-01-8.mol | |
| DYRKs-IN-1 Chemical Properties |
density | 1.53±0.1 g/cm3(Predicted) | pka | 10.84±0.70(Predicted) |
| DYRKs-IN-1 Usage And Synthesis |
Description | DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor and has antitumor activity. | in vitro | From a data-mining effort, the team has discovered analogues of pyrido[2,3-d]pyrimidines as potent enantio-selective inhibitors of DYRK1B. Cells treated with a tool compound from this series showed the same cellular effects as down regulation of DYRK1B with siRNA._x000D_
_x000D_
Reference: Bioorg Med Chem Lett. 2013 Dec 15;23(24):6610-5. https://pubmed.ncbi.nlm.nih.gov/24239188/ | target | DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 5 nM and 8 nM for DYRK1A and DYRK1B, respectively. |
| DYRKs-IN-1 Preparation Products And Raw materials |
|